Federal Circuit Limits the Safe Harbor Provision and the Scope of § 271(g) - Momenta Pharm., Inc. v. Teva Pharm., Inc. and Amphastar Pharmaceuticals, Inc.
By EsqSocial Corporation 28/12/15
Addressing issues of infringement under 35 U.S.C. § 271(g) and the safe harbor provision of § 271(e), the U.S. Court of Appeals for the Federal Circuit upheld the district court’s ruling of non-infringement under § 271(g) and vacated the district...
By: McDermott Will & Emery